Clinical trials
Phase 2/3 Malaria trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 2 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 3 |
| 2019 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Terminated | 2 |
| Withdrawn | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| London School of Hygiene and Tropical Medicine | 10 |
| Centers for Disease Control and Prevention | 2 |
| Novartis Pharmaceuticals | 2 |
| Oswaldo Cruz Foundation | 2 |
| Centro de Investigacao em Saude de Manhica | 1 |
| Claude Bernard University | 1 |
| Colorado State University | 1 |
| Institute of Tropical Medicine, Belgium | 1 |
| Medicines for Malaria Venture | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Malaria | 24 |
| Malaria, Falciparum | 7 |
| Diarrhea | 1 |
| Elephantiasis, Filarial | 1 |
| Glucosephosphate Dehydrogenase Deficiency | 1 |
| Influenza, Human | 1 |
| Malaria, Cerebral | 1 |
| Malaria, Vivax | 1 |
| Poliomyelitis | 1 |
| Tetanus | 1 |
Trials
Showing 26 to 24 of 24. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.